Clinical Trial Update: A Study to Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing neostigmine with sugammadex for reducing length of stay in the PACU after sleeve gastrectomy; the study is terminated with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting
• Respiratory Conditions Due to Other External Agents

Drugs mentioned

• Neostigmine (neostigmine)
• Sugammadex (sugammadex)

Snippet

Sponsor: Virtua Health, Inc. | Conditions: Postoperative Nausea and Vomiting, Respiratory Conditions Due to Other External Agents | Phase 4 | Status: TERMINATED | Results posted: 2019-05-28